UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?

Current opinion in HIV & AIDS, 2022-07, Vol.17 (4), p.213

2022

Link zum Volltext

Verfügbarkeit prüfen

Histopathological Spectrum of Spinal Tumours at a Tertiary Care Hospital, Gujarat, India: A Retrospective Study

Journal of clinical and diagnostic research, 2023, Vol.17 (1), p.EC05-EC09

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?

Current HIV/AIDS reports, 2022-10, Vol.19 (5), p.384-393

2022

Link zum Volltext

Verfügbarkeit prüfen

Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?

Current opinion in HIV & AIDS, 2016-01, Vol.11 (1), p.49

2016

Link zum Volltext

Verfügbarkeit prüfen

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e630-e644

2022

Link zum Volltext

Verfügbarkeit prüfen

Potential Impact and Cost-Effectiveness of Condomless-Sex–Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance

The Journal of infectious diseases, 2021-04, Vol.223 (8), p.1345-1355

2021

Link zum Volltext

Verfügbarkeit prüfen

Complete Protection from Repeated Vaginal Simian-Human Immunodeficiency Virus Exposures in Macaques by a Topical Gel Containing Tenofovir Alone or with Emtricitabine

Journal of Virology, 2009-10, Vol.83 (20), p.10358-10365

2009

Link zum Volltext

Verfügbarkeit prüfen

Future technologies for monitoring HIV drug resistance and cure

Current opinion in HIV & AIDS, 2017-03, Vol.12 (2), p.182

2017

Link zum Volltext

Verfügbarkeit prüfen

Brief Report: HIV Drug Resistance Assessment Among Women Who Seroconverted During the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial

Journal of acquired immune deficiency syndromes (1999), 2024-01, Vol.95 (1), p.35

2024

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa

Clinical infectious diseases, 2016-08, Vol.63 (4), p.539-547

2016

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

The New England journal of medicine, 2015-02, Vol.372 (6), p.509-518

2015

Link zum Volltext

Verfügbarkeit prüfen

Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA)

The Journal of infectious diseases, 2016-03, Vol.213 (6), p.1013-1017

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009)

PloS one, 2013-04, Vol.8 (4), p.e59787-e59787

2013

Link zum Volltext

Verfügbarkeit prüfen

Immune Status and SARS-CoV-2 Viral Dynamics

The Journal of infectious diseases, 2023-08, Vol.228 (Supplement_2), p.S111-S116

2023

Link zum Volltext

Verfügbarkeit prüfen

The K65R Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Exhibits Bidirectional Phenotypic Antagonism with Thymidine Analog Mutations

Journal of Virology, 2006-05, Vol.80 (10), p.4971-4977

2006

Link zum Volltext

Verfügbarkeit prüfen

Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer

Journal of virological methods, 2023-06, Vol.316, p.114726-114726, Article 114726

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the Microbicide Trials Network-020 Phase III Trial of the Dapivirine Vaginal Ring

Clinical infectious diseases, 2019-07, Vol.69 (3), p.523-529

2019

Link zum Volltext

Verfügbarkeit prüfen

Discordance between Etravirine Phenotype and Genotype-Based Predicted Phenotype for Subtype C HIV-1 from First-Line Antiretroviral Therapy Failures in South Africa

Antimicrobial agents and chemotherapy, 2020-04, Vol.64 (5)

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase

AIDS (London), 2007-07, Vol.21 (11), p.1405-1414

2007

Link zum Volltext

Verfügbarkeit prüfen

Molecular Mechanism by Which the K70E Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Resistance to Nucleoside Reverse Transcriptase Inhibitors

Antimicrobial Agents and Chemotherapy, 2007-01, Vol.51 (1), p.48-53

2007

Link zum Volltext

Verfügbarkeit prüfen

Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost‐effectiveness

Journal of the International AIDS Society, 2019-05, Vol.22 (5), p.e25282-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa

Antimicrobial agents and chemotherapy, 2017-02, Vol.61 (2)

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(86)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(59)
Humans
(50)
Infectious Diseases
(40)
Immunology
(31)
Microbiology
(29)
Female
(28)
Hiv
(27)
Human Immunodeficiency Virus
(24)
Hiv Infections - Drug Therapy
(21)
Hiv Infections - Prevention & Control
(20)
Adult
(19)
Anti-Hiv Agents - Therapeutic Use
(17)
Drug Resistance
(16)
Hiv-1 - Genetics
(15)
Pre-Exposure Prophylaxis
(14)
Mutation
(13)
Antiviral Agents
(12)
Clinical Trials
(12)
Male
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?

Histopathological Spectrum of Spinal Tumours at a Tertiary Care Hospital, Gujarat, India: A Retrospective Study

Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?

Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)

Potential Impact and Cost-Effectiveness of Condomless-Sex–Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance

Complete Protection from Repeated Vaginal Simian-Human Immunodeficiency Virus Exposures in Macaques by a Topical Gel Containing Tenofovir Alone or with Emtricitabine

Future technologies for monitoring HIV drug resistance and cure

Brief Report: HIV Drug Resistance Assessment Among Women Who Seroconverted During the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial

Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA)

Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised Individuals

Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009)

Immune Status and SARS-CoV-2 Viral Dynamics

The K65R Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Exhibits Bidirectional Phenotypic Antagonism with Thymidine Analog Mutations

Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer

Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study

Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the Microbicide Trials Network-020 Phase III Trial of the Dapivirine Vaginal Ring

MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel

Discordance between Etravirine Phenotype and Genotype-Based Predicted Phenotype for Subtype C HIV-1 from First-Line Antiretroviral Therapy Failures in South Africa

Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase

Molecular Mechanism by Which the K70E Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Resistance to Nucleoside Reverse Transcriptase Inhibitors

Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost‐effectiveness

Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa

Suchergebnisse filtern